Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
For the full year, sales was INR 4,142.53 million compared to INR 4,926.8 million a year ago. Revenue was INR 4,216.86 million compared to INR 4,954.28 million a year ago. Net income was INR 37.77 million compared to INR 65.45 million a year ago. Basic earnings per share from continuing operations was INR 1.49 compared to INR 2.72 a year ago. Diluted earnings per share from continuing operations was INR 1.49 compared to INR 2.72 a year ago.